Summary
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support basic research, discovery, and/or preclinical development of highly efficacious vaccines for malaria and potentially other mosquito-borne illness. The program will encourage novel approaches to vaccine design that capitalize on recent technological innovations including structure-based immunogen design, and/or combination vaccines to reduce parasite infection and/or reduce malaria disease burden. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Eligibility
- Public and Indian Housing Authorities
- Special District Governments
- City Or Township Governments
- Private Institutions of Higher Education
- Native American Tribal Governments Federally Recognized
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- Other
- County Governments
- Small Businesses
- Nonprofits Non Higher Education Without 501c3
- Independent School Districts
- State Governments
- For Profit Organizations Other Than Small Businesses
- Public and State Institutions of Higher Education
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
Funding categories
- Health
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record